跳到主要内容
  • Sign in
    Welcome !
    My account
    Logout

NEOGENOMICS INC (NEO) Stock Forecast 2025 - AI Price Prediction & Analysis

NEOGENOMICS INC (NEO) AI Stock Price Forecast & Investment Analysis

NEOGENOMICS INC Stock Price Chart and Technical Analysis

Loading NEOGENOMICS INC interactive price chart and technical analysis...

NEOGENOMICS INC (NEO) - Comprehensive Stock Analysis & Investment Research

Deep dive into NEOGENOMICS INC's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about NEOGENOMICS INC, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For NEOGENOMICS INC: NEOGENOMICS INC operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

NEOGENOMICS INC (Stock Symbol: NEO) is a leading company in the Industrial Applications and Services sector , specifically operating within the Services-Testing Laboratories industry.

The organization employs approximately 1600 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing NEOGENOMICS INC's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For NEOGENOMICS INC: With $63M in annual revenue and -79.7% net margin, the company demonstrates developing profitability.

Annual Revenue: $63 million generating a -79.7% net profit margin .

Market Capitalization: $1011 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -3.7% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for NEOGENOMICS INC stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For NEOGENOMICS INC: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for NEOGENOMICS INC stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: NEOGENOMICS INC's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For NEOGENOMICS INC: Market positioning analysis based on available financial and operational metrics.

NEOGENOMICS INC strategically competes in the highly dynamic Services-Testing Laboratories marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 442.2% gross margin, indicating strong pricing power and operational efficiency.

NEOGENOMICS INC (NEO) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for NEOGENOMICS INC stock analysis.

Loading NEOGENOMICS INC comprehensive fundamental analysis and insider trading data...

Deep dive into NEOGENOMICS INC's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if NEOGENOMICS INC stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For NEOGENOMICS INC: With a P/E ratio of -64.89, the market sees the stock as potentially undervalued.

P/E Ratio -64.89x
P/B Ratio 1.18x
Market Cap $1011M
EPS $-0.07
Book Value/Share $6.64
Revenue/Share $4.91
FCF/Share $-0.23
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently NEOGENOMICS INC converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For NEOGENOMICS INC: An ROE of -3.7% indicates room for improvement in shareholder value creation.

ROE -3.7%
ROA -2.1%
ROIC -2.3%
Gross Margin 442.2%
Operating Margin -145.5%
Net Margin -79.7%
EBT Margin -9.7%
Tax Rate 31.0%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess NEOGENOMICS INC's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For NEOGENOMICS INC: A current ratio of 7.93 indicates strong liquidity.

Current Ratio 7.93x
Quick Ratio 7.22x
D/E Ratio 0.56x
Financial Leverage 1.70x
Interest Coverage -2.0x
Working Capital $376M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal NEOGENOMICS INC's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For NEOGENOMICS INC: Free cash flow of $-115M indicates cash challenges that need attention.

Operating Cash Flow $-58M
Free Cash Flow $-115M
Capital Spending $-57M
OCF Growth YoY -93.8%
FCF Growth YoY -89.0%
FCF/Sales -23.6%
CapEx/Sales 11.6%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively NEOGENOMICS INC uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For NEOGENOMICS INC: An asset turnover of 0.29x suggests room for improvement in asset utilization.

Asset Turnover 0.29x
Receivables Turnover 4.6x
Inventory Turnover 13.4x
Fixed Assets Turnover 2.6x
Days Sales Outstanding 80 days
Days Inventory 27 days
Payables Period 24 days
Cash Conversion Cycle 84 days
Understanding Financial Statement Data

What these metrics mean: Key figures from NEOGENOMICS INC's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For NEOGENOMICS INC: With annual revenue of $63M, NEOGENOMICS INC represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $63M
R&D Expense $30M
SG&A Expense $64M
Cost of Goods Sold $364M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 36%
Cash & Short-term Investments 26%
Total Liabilities 41%
Short-term Debt 0%
Accounts Receivable 6%
Inventory 1%
Dividend & Shareholder Information
Shares Outstanding 129M
Growth Metrics (YoY)
EPS Growth -0.4%

Latest NEOGENOMICS INC Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting NEOGENOMICS INC (NEO) stock price and investment outlook.

, source: Benzinga

NeoGenomics (NEO) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of their recent ...

NEOGENOMICS INC Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of NEOGENOMICS INC against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
APDN Unlock Forecast - 30 Days FREE Trial $2M 0.0x 0.3x
NEO Unlock Forecast - 30 Days FREE Trial $1011M -64.9x 1.2x
ULS Unlock Forecast - 30 Days FREE Trial $13563M 41.5x 12.4x

Frequently Asked Questions - NEOGENOMICS INC Stock Forecast

How accurate are NEOGENOMICS INC stock predictions?

Our AI model demonstrates 60% historical accuracy for NEO predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence NEOGENOMICS INC stock price forecasts?

Our analysis considers NEOGENOMICS INC's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is NEOGENOMICS INC a good investment in 2025?

Based on our AI analysis, NEOGENOMICS INC shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are NEOGENOMICS INC forecasts updated?

NEOGENOMICS INC stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced NEOGENOMICS INC Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for NEOGENOMICS INC stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...